Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Service & Software > Beta-Glucan Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Beta-Glucan Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Beta-Glucan Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published: 2026-02-11

Pages: 105 Pages

Report ld: 5940057

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Beta-Glucan Test was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

Beta-glucan is a type of soluble fiber found in certain foods, such as oats, barley, mushrooms, and yeast. It is believed to have several health benefits, including improving heart health, immune function, and cholesterol levels.
The North American market for Beta-Glucan Test was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Beta-Glucan Test was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Beta-Glucan Test was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Beta-Glucan Test market include Exeter Clinical Laboratory, MiraVista Diagnostics, Biothera Pharmaceuticals, Viapath, HealthLink, FUJIFILM Wako, Leeds Teaching Hospitals NHS Trust, Asymchem Laboratories, The Doctors Laboratory, Eurofins Scientific, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Beta-Glucan Test, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Beta-Glucan Test market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Beta-Glucan Test.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Beta-Glucan Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

  • Market Size Available for Years

  • 2026-2032

  • Global Beta-Glucan Test Companies Covered

  • Exeter Clinical Laboratory

    MiraVista Diagnostics

    Biothera Pharmaceuticals

    Viapath

    HealthLink

    FUJIFILM Wako

    Leeds Teaching Hospitals NHS Trust

    Asymchem Laboratories

    The Doctors Laboratory

    Eurofins Scientific

    Criver

    Almac Group

  • Global Beta-Glucan Test Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Beta-Glucan Test Market, Segment by Type

  • Blood Tests

    Urine Tests

    Saliva Tests

  • Global Beta-Glucan Test Market, Segment by Application

  • Hospital

    Clinic

    Other

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Beta-Glucan Test companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Beta-Glucan Test revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Beta-Glucan Test revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Beta-Glucan Test Product Introduction
    1.2 Global Beta-Glucan Test Market Size Forecast (2021–2032)
    1.3 Beta-Glucan Test Market Trends & Drivers
        1.3.1 Beta-Glucan Test Industry Trends
        1.3.2 Beta-Glucan Test Market Drivers & Opportunities
        1.3.3 Beta-Glucan Test Market Challenges
        1.3.4 Beta-Glucan Test Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Beta-Glucan Test Players Revenue Ranking (2025)
    2.2 Global Beta-Glucan Test Revenue by Company (2021–2026)
    2.3 Key Companies’ R&D and Operations Footprint and Headquarters
    2.4 Key Companies Beta-Glucan Test Product Offerings
    2.5 Key Companies General Availability (GA) Timeline for Beta-Glucan Test
    2.6 Beta-Glucan Test Market Competitive Analysis
        2.6.1 Beta-Glucan Test Market Concentration Rate (2021–2026)
        2.6.2 Top 5 and Top 10 Global Companies by Beta-Glucan Test Revenue in 2025
        2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Beta-Glucan Test revenue, 2025
    2.7 Mergers & Acquisitions and Expansion
3 Segmentation Beta-Glucan Test Market Classification
    3.1 Introduction by Type
        3.1.1 Blood Tests
        3.1.2 Urine Tests
        3.1.3 Saliva Tests
        3.1.4 Global Beta-Glucan Test Sales Value by Type
            3.1.4.1 Global Beta-Glucan Test Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.4.2 Global Beta-Glucan Test Sales Value, by Type (2021–2032)
            3.1.4.3 Global Beta-Glucan Test Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Other
    4.2 Global Beta-Glucan Test Sales Value by Application
        4.2.1 Global Beta-Glucan Test Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Beta-Glucan Test Sales Value by Application (2021–2032)
        4.2.3 Global Beta-Glucan Test Sales Value by Application (%), 2021–2032
5 Segmentation by Region
    5.1 Global Beta-Glucan Test Sales Value by Region
        5.1.1 Global Beta-Glucan Test Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Beta-Glucan Test Sales Value by Region (2021–2026)
        5.1.3 Global Beta-Glucan Test Sales Value by Region (2027–2032)
        5.1.4 Global Beta-Glucan Test Sales Value by Region (%), 2021–2032
    5.2 North America
        5.2.1 North America Beta-Glucan Test Sales Value, 2021–2032
        5.2.2 North America Beta-Glucan Test Sales Value by Country (%), 2025 vs 2032
    5.3 Europe
        5.3.1 Europe Beta-Glucan Test Sales Value, 2021–2032
        5.3.2 Europe Beta-Glucan Test Sales Value by Country (%), 2025 vs 2032
    5.4 Asia Pacific
        5.4.1 Asia Pacific Beta-Glucan Test Sales Value, 2021–2032
        5.4.2 Asia Pacific Beta-Glucan Test Sales Value by Subregion (%), 2025 vs 2032
    5.5 South America
        5.5.1 South America Beta-Glucan Test Sales Value, 2021–2032
        5.5.2 South America Beta-Glucan Test Sales Value by Country (%), 2025 vs 2032
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Beta-Glucan Test Sales Value, 2021–2032
        5.6.2 Middle East & Africa Beta-Glucan Test Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Beta-Glucan Test Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Beta-Glucan Test Sales Value, 2021–2032
    6.3 United States
        6.3.1 United States Beta-Glucan Test Sales Value, 2021–2032
        6.3.2 United States Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Beta-Glucan Test Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Beta-Glucan Test Sales Value, 2021–2032
        6.4.2 Europe Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Beta-Glucan Test Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Beta-Glucan Test Sales Value, 2021–2032
        6.5.2 China Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Beta-Glucan Test Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Beta-Glucan Test Sales Value, 2021–2032
        6.6.2 Japan Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Beta-Glucan Test Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Beta-Glucan Test Sales Value, 2021–2032
        6.7.2 South Korea Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Beta-Glucan Test Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Beta-Glucan Test Sales Value, 2021–2032
        6.8.2 Southeast Asia Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Beta-Glucan Test Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Beta-Glucan Test Sales Value, 2021–2032
        6.9.2 India Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Beta-Glucan Test Sales Value by Application, 2025 vs 2032
7 Company Profiles
    7.1 Exeter Clinical Laboratory
        7.1.1 Exeter Clinical Laboratory Profile
        7.1.2 Exeter Clinical Laboratory Main Business
        7.1.3 Exeter Clinical Laboratory Beta-Glucan Test Products, Services, and Solutions
        7.1.4 Exeter Clinical Laboratory Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.1.5 Exeter Clinical Laboratory Recent Developments
    7.2 MiraVista Diagnostics
        7.2.1 MiraVista Diagnostics Profile
        7.2.2 MiraVista Diagnostics Main Business
        7.2.3 MiraVista Diagnostics Beta-Glucan Test Products, Services, and Solutions
        7.2.4 MiraVista Diagnostics Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.2.5 MiraVista Diagnostics Recent Developments
    7.3 Biothera Pharmaceuticals
        7.3.1 Biothera Pharmaceuticals Profile
        7.3.2 Biothera Pharmaceuticals Main Business
        7.3.3 Biothera Pharmaceuticals Beta-Glucan Test Products, Services, and Solutions
        7.3.4 Biothera Pharmaceuticals Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.3.5 Biothera Pharmaceuticals Recent Developments
    7.4 Viapath
        7.4.1 Viapath Profile
        7.4.2 Viapath Main Business
        7.4.3 Viapath Beta-Glucan Test Products, Services, and Solutions
        7.4.4 Viapath Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.4.5 Viapath Recent Developments
    7.5 HealthLink
        7.5.1 HealthLink Profile
        7.5.2 HealthLink Main Business
        7.5.3 HealthLink Beta-Glucan Test Products, Services, and Solutions
        7.5.4 HealthLink Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.5.5 HealthLink Recent Developments
    7.6 FUJIFILM Wako
        7.6.1 FUJIFILM Wako Profile
        7.6.2 FUJIFILM Wako Main Business
        7.6.3 FUJIFILM Wako Beta-Glucan Test Products, Services, and Solutions
        7.6.4 FUJIFILM Wako Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.6.5 FUJIFILM Wako Recent Developments
    7.7 Leeds Teaching Hospitals NHS Trust
        7.7.1 Leeds Teaching Hospitals NHS Trust Profile
        7.7.2 Leeds Teaching Hospitals NHS Trust Main Business
        7.7.3 Leeds Teaching Hospitals NHS Trust Beta-Glucan Test Products, Services, and Solutions
        7.7.4 Leeds Teaching Hospitals NHS Trust Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.7.5 Leeds Teaching Hospitals NHS Trust Recent Developments
    7.8 Asymchem Laboratories
        7.8.1 Asymchem Laboratories Profile
        7.8.2 Asymchem Laboratories Main Business
        7.8.3 Asymchem Laboratories Beta-Glucan Test Products, Services, and Solutions
        7.8.4 Asymchem Laboratories Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.8.5 Asymchem Laboratories Recent Developments
    7.9 The Doctors Laboratory
        7.9.1 The Doctors Laboratory Profile
        7.9.2 The Doctors Laboratory Main Business
        7.9.3 The Doctors Laboratory Beta-Glucan Test Products, Services, and Solutions
        7.9.4 The Doctors Laboratory Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.9.5 The Doctors Laboratory Recent Developments
    7.10 Eurofins Scientific
        7.10.1 Eurofins Scientific Profile
        7.10.2 Eurofins Scientific Main Business
        7.10.3 Eurofins Scientific Beta-Glucan Test Products, Services, and Solutions
        7.10.4 Eurofins Scientific Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.10.5 Eurofins Scientific Recent Developments
    7.11 Criver
        7.11.1 Criver Profile
        7.11.2 Criver Main Business
        7.11.3 Criver Beta-Glucan Test Products, Services, and Solutions
        7.11.4 Criver Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.11.5 Criver Recent Developments
    7.12 Almac Group
        7.12.1 Almac Group Profile
        7.12.2 Almac Group Main Business
        7.12.3 Almac Group Beta-Glucan Test Products, Services, and Solutions
        7.12.4 Almac Group Beta-Glucan Test Revenue (US$ Million), 2021–2026
        7.12.5 Almac Group Recent Developments
8 Industry Chain Analysis
    8.1 Beta-Glucan Test Value Chain
    8.2 Beta-Glucan Test Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream (Customer) Analysis
    8.5 Sales Model and Sales Channelss
        8.5.1 Beta-Glucan Test Sales Model
        8.5.2 Sales Channels
        8.5.3 Beta-Glucan Test Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Beta-Glucan Test Market Trends
 Table 2. Beta-Glucan Test Market Drivers & Opportunities
 Table 3. Beta-Glucan Test Market Challenges
 Table 4. Beta-Glucan Test Market Restraints
 Table 5. Global Beta-Glucan Test Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Beta-Glucan Test Revenue Market Share by Company (2021–2026)
 Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
 Table 8. Key Companies Beta-Glucan Test Product Type
 Table 9. Key Companies General Availability (GA) Timeline for Beta-Glucan Test
 Table 10. Global Beta-Glucan Test Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Beta-Glucan Test revenue, 2025
 Table 12. Mergers & Acquisitions and Expansion Plans
 Table 13. Global Beta-Glucan Test Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 14. Global Beta-Glucan Test Sales Value by Type (US$ Million), 2021–2026
 Table 15. Global Beta-Glucan Test Sales Value by Type (US$ Million), 2027–2032
 Table 16. Global Beta-Glucan Test Sales Market Share in Value by Type (2021–2026)
 Table 17. Global Beta-Glucan Test Sales Market Share in Value by Type (2027–2032)
 Table 18. Global Beta-Glucan Test Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 19. Global Beta-Glucan Test Sales Value by Application (US$ Million), 2021–2026
 Table 20. Global Beta-Glucan Test Sales Value by Application (US$ Million), 2027–2032
 Table 21. Global Beta-Glucan Test Sales Market Share in Value by Application (2021–2026)
 Table 22. Global Beta-Glucan Test Sales Market Share in Value by Application (2027–2032)
 Table 23. Global Beta-Glucan Test Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 24. Global Beta-Glucan Test Sales Value by Region (US$ Million), 2021–2026
 Table 25. Global Beta-Glucan Test Sales Value by Region (US$ Million), 2027–2032
 Table 26. Global Beta-Glucan Test Sales Value by Region (%), 2021–2026
 Table 27. Global Beta-Glucan Test Sales Value by Region (%), 2027–2032
 Table 28. Key Countries/Regions Beta-Glucan Test Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 29. Key Countries/Regions Beta-Glucan Test Sales Value, (US$ Million), 2021–2026
 Table 30. Key Countries/Regions Beta-Glucan Test Sales Value, (US$ Million), 2027–2032
 Table 31. Exeter Clinical Laboratory Basic Information List
 Table 32. Exeter Clinical Laboratory Description and Business Overview
 Table 33. Exeter Clinical Laboratory Beta-Glucan Test Products, Services, and Solutions
 Table 34. Revenue (US$ Million) in Beta-Glucan Test Business of Exeter Clinical Laboratory (2021–2026)
 Table 35. Exeter Clinical Laboratory Recent Developments
 Table 36. MiraVista Diagnostics Basic Information List
 Table 37. MiraVista Diagnostics Description and Business Overview
 Table 38. MiraVista Diagnostics Beta-Glucan Test Products, Services, and Solutions
 Table 39. Revenue (US$ Million) in Beta-Glucan Test Business of MiraVista Diagnostics (2021–2026)
 Table 40. MiraVista Diagnostics Recent Developments
 Table 41. Biothera Pharmaceuticals Basic Information List
 Table 42. Biothera Pharmaceuticals Description and Business Overview
 Table 43. Biothera Pharmaceuticals Beta-Glucan Test Products, Services, and Solutions
 Table 44. Revenue (US$ Million) in Beta-Glucan Test Business of Biothera Pharmaceuticals (2021–2026)
 Table 45. Biothera Pharmaceuticals Recent Developments
 Table 46. Viapath Basic Information List
 Table 47. Viapath Description and Business Overview
 Table 48. Viapath Beta-Glucan Test Products, Services, and Solutions
 Table 49. Revenue (US$ Million) in Beta-Glucan Test Business of Viapath (2021–2026)
 Table 50. Viapath Recent Developments
 Table 51. HealthLink Basic Information List
 Table 52. HealthLink Description and Business Overview
 Table 53. HealthLink Beta-Glucan Test Products, Services, and Solutions
 Table 54. Revenue (US$ Million) in Beta-Glucan Test Business of HealthLink (2021–2026)
 Table 55. HealthLink Recent Developments
 Table 56. FUJIFILM Wako Basic Information List
 Table 57. FUJIFILM Wako Description and Business Overview
 Table 58. FUJIFILM Wako Beta-Glucan Test Products, Services, and Solutions
 Table 59. Revenue (US$ Million) in Beta-Glucan Test Business of FUJIFILM Wako (2021–2026)
 Table 60. FUJIFILM Wako Recent Developments
 Table 61. Leeds Teaching Hospitals NHS Trust Basic Information List
 Table 62. Leeds Teaching Hospitals NHS Trust Description and Business Overview
 Table 63. Leeds Teaching Hospitals NHS Trust Beta-Glucan Test Products, Services, and Solutions
 Table 64. Revenue (US$ Million) in Beta-Glucan Test Business of Leeds Teaching Hospitals NHS Trust (2021–2026)
 Table 65. Leeds Teaching Hospitals NHS Trust Recent Developments
 Table 66. Asymchem Laboratories Basic Information List
 Table 67. Asymchem Laboratories Description and Business Overview
 Table 68. Asymchem Laboratories Beta-Glucan Test Products, Services, and Solutions
 Table 69. Revenue (US$ Million) in Beta-Glucan Test Business of Asymchem Laboratories (2021–2026)
 Table 70. Asymchem Laboratories Recent Developments
 Table 71. The Doctors Laboratory Basic Information List
 Table 72. The Doctors Laboratory Description and Business Overview
 Table 73. The Doctors Laboratory Beta-Glucan Test Products, Services, and Solutions
 Table 74. Revenue (US$ Million) in Beta-Glucan Test Business of The Doctors Laboratory (2021–2026)
 Table 75. The Doctors Laboratory Recent Developments
 Table 76. Eurofins Scientific Basic Information List
 Table 77. Eurofins Scientific Description and Business Overview
 Table 78. Eurofins Scientific Beta-Glucan Test Products, Services, and Solutions
 Table 79. Revenue (US$ Million) in Beta-Glucan Test Business of Eurofins Scientific (2021–2026)
 Table 80. Eurofins Scientific Recent Developments
 Table 81. Criver Basic Information List
 Table 82. Criver Description and Business Overview
 Table 83. Criver Beta-Glucan Test Products, Services, and Solutions
 Table 84. Revenue (US$ Million) in Beta-Glucan Test Business of Criver (2021–2026)
 Table 85. Criver Recent Developments
 Table 86. Almac Group Basic Information List
 Table 87. Almac Group Description and Business Overview
 Table 88. Almac Group Beta-Glucan Test Products, Services, and Solutions
 Table 89. Revenue (US$ Million) in Beta-Glucan Test Business of Almac Group (2021–2026)
 Table 90. Almac Group Recent Developments
 Table 91. Revenue (US$ Million) in Beta-Glucan Test Business of Company 40 (2021–2026)
 Table 92. Company 40 Recent Developments
 Table 93. Key Raw Materials Lists
 Table 94. Key Suppliers of Raw Materials Lists
 Table 95. Beta-Glucan Test Downstream Customers
 Table 96. Beta-Glucan Test Distributors List
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources


List of Figures
 Figure 1. Beta-Glucan Test Product Picture
 Figure 2. Global Beta-Glucan Test Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 4. Beta-Glucan Test Report Years Considered
 Figure 5. Global Beta-Glucan Test Players Revenue Ranking (US$ Million), 2025
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Beta-Glucan Test Revenue in 2025
 Figure 7. Beta-Glucan Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 8. Blood Tests Picture
 Figure 9. Urine Tests Picture
 Figure 10. Saliva Tests Picture
 Figure 11. Global Beta-Glucan Test Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Beta-Glucan Test Sales Value Market Share by Type, 2025 & 2032
 Figure 13. Product Picture of Hospital
 Figure 14. Product Picture of Clinic
 Figure 15. Product Picture of Other
 Figure 16. Global Beta-Glucan Test Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Beta-Glucan Test Sales Value Market Share by Application, 2025 & 2032
 Figure 18. North America Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 19. North America Beta-Glucan Test Sales Value by Country (%), 2025 vs 2032
 Figure 20. Europe Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 21. Europe Beta-Glucan Test Sales Value by Country (%), 2025 vs 2032
 Figure 22. Asia Pacific Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 23. Asia Pacific Beta-Glucan Test Sales Value by Subregion (%), 2025 vs 2032
 Figure 24. South America Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 25. South America Beta-Glucan Test Sales Value by Country (%), 2025 vs 2032
 Figure 26. Middle East & Africa Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 27. Middle East & Africa Beta-Glucan Test Sales Value by Country (%), 2025 vs 2032
 Figure 28. Key Countries/Regions Beta-Glucan Test Sales Value (%), 2021–2032
 Figure 29. United States Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 30. United States Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
 Figure 31. United States Beta-Glucan Test Sales Value by Application (%), 2025 vs 2032
 Figure 32. Europe Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 33. Europe Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
 Figure 34. Europe Beta-Glucan Test Sales Value by Application (%), 2025 vs 2032
 Figure 35. China Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 36. China Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
 Figure 37. China Beta-Glucan Test Sales Value by Application (%), 2025 vs 2032
 Figure 38. Japan Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 39. Japan Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
 Figure 40. Japan Beta-Glucan Test Sales Value by Application (%), 2025 vs 2032
 Figure 41. South Korea Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 42. South Korea Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
 Figure 43. South Korea Beta-Glucan Test Sales Value by Application (%), 2025 vs 2032
 Figure 44. Southeast Asia Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 45. Southeast Asia Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
 Figure 46. Southeast Asia Beta-Glucan Test Sales Value by Application (%), 2025 vs 2032
 Figure 47. India Beta-Glucan Test Sales Value (US$ Million), 2021–2032
 Figure 48. India Beta-Glucan Test Sales Value by Type (%), 2025 vs 2032
 Figure 49. India Beta-Glucan Test Sales Value by Application (%), 2025 vs 2032
 Figure 50. Beta-Glucan Test Value Chain
 Figure 51. Beta-Glucan Test Cost Structure
 Figure 52. Channels of Distribution (Direct Sales, and Distribution)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed

Description

The global market for Beta-Glucan Test was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

Beta-glucan is a type of soluble fiber found in certain foods, such as oats, barley, mushrooms, and yeast. It is believed to have several health benefits, including improving heart health, immune function, and cholesterol levels.
The North American market for Beta-Glucan Test was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Beta-Glucan Test was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Beta-Glucan Test was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Beta-Glucan Test market include Exeter Clinical Laboratory, MiraVista Diagnostics, Biothera Pharmaceuticals, Viapath, HealthLink, FUJIFILM Wako, Leeds Teaching Hospitals NHS Trust, Asymchem Laboratories, The Doctors Laboratory, Eurofins Scientific, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Beta-Glucan Test, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Beta-Glucan Test market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Beta-Glucan Test.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Beta-Glucan Test companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Beta-Glucan Test revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Beta-Glucan Test revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Beta-Glucan Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published: 2026-02-11

Pages: 105 Pages

Report ld: 5940057

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now